Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYSE

78.17 May 17, 4:05PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):3.0
Mean Recommendation (last week):3.4
Change:-0.4

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:52.38
Median Target:50.00
High Target:75.00
Low Target:34.50
No. of Brokers:4

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Feb 21, 2013Aegis CapitalInitiated Buy
Feb 4, 2010Jefferies & CoInitiated Buy
Jul 8, 2009Leerink SwannDowngradeOutperformMkt Perform
Jun 8, 2009WachoviaDowngradeMkt PerformUnderperform
May 13, 2009SoleilInitiated Sell
May 13, 2009Ladenburg ThalmannInitiated Neutral
Mar 23, 2009Leerink SwannInitiated Outperform
Oct 27, 2008Brean MurrayInitiated Sell
Sep 22, 2008Lazard CapitalUpgradeSellHold
Mar 16, 2008Lazard CapitalDowngradeHoldSell

More Upgrades & Downgrades for VRX

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0555
Buy0987
Hold0444
Underperform0111
Sell0000

Data provided by Thomson/First Call


Currency in USD.